These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 30965050

  • 1. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
    Ikemura N, Yamaori S, Kobayashi C, Kamijo S, Murayama N, Yamazaki H, Ohmori S.
    Chem Biol Interact; 2019 Jun 01; 306():1-9. PubMed ID: 30965050
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T.
    Eur J Clin Pharmacol; 2000 Jun 01; 55(11-12):843-52. PubMed ID: 10805063
    [Abstract] [Full Text] [Related]

  • 3. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J, Liu D, Zhou X, Chen A, Jiang Z, Ye X, Liu M, Wang X.
    Phytomedicine; 2018 Jan 15; 39():137-145. PubMed ID: 29433675
    [Abstract] [Full Text] [Related]

  • 4. Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.
    Karkhanis A, Lam HY, Venkatesan G, Koh SK, Chai CL, Zhou L, Hong Y, Kojodjojo P, Chan EC.
    Biochem Pharmacol; 2016 May 01; 107():67-80. PubMed ID: 26972388
    [Abstract] [Full Text] [Related]

  • 5. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
    Furukawa T, Nukada T, Namiki Y, Miyashita Y, Hatsuno K, Ueno Y, Yamakawa T, Isshiki T.
    Eur J Pharmacol; 2009 Jun 24; 613(1-3):100-7. PubMed ID: 19401195
    [Abstract] [Full Text] [Related]

  • 6. Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions.
    Uesawa Y, Takeuchi T, Mohri K.
    Curr Pharm Biotechnol; 2012 Jul 24; 13(9):1705-17. PubMed ID: 22039822
    [Abstract] [Full Text] [Related]

  • 7. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E, Wu Z, Shon JC, Liu KH.
    Drug Metab Dispos; 2015 Aug 24; 43(8):1250-3. PubMed ID: 26048912
    [Abstract] [Full Text] [Related]

  • 8. The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2.
    Tian X, Zhou M, Ning J, Deng X, Feng L, Huang H, Yao D, Ma X.
    J Enzyme Inhib Med Chem; 2021 Dec 24; 36(1):737-748. PubMed ID: 33682565
    [Abstract] [Full Text] [Related]

  • 9. Effect of benidipine on simvastatin metabolism in human liver microsomes.
    Sugiyama Y, Mimura N, Kuwabara T, Kobayashi H, Ushiki J, Fuse E.
    Drug Metab Pharmacokinet; 2007 Jun 24; 22(3):199-205. PubMed ID: 17603221
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.
    Katoh M, Nakajima M, Yamazaki H, Yokoi T.
    Pharm Res; 2000 Oct 24; 17(10):1189-97. PubMed ID: 11145223
    [Abstract] [Full Text] [Related]

  • 11. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM, Wu Z, O Y, Lee JH, Oh S, Song GY, Liu KH.
    Drug Metab Dispos; 2017 Jul 24; 45(7):765-769. PubMed ID: 28461575
    [Abstract] [Full Text] [Related]

  • 12. The actions of azelnidipine, a dihydropyridine-derivative Ca antagonist, on voltage-dependent Ba2+ currents in guinea-pig vascular smooth muscle.
    Zhu HL, Tomoda T, Aishima M, Ito Y, Teramoto N.
    Br J Pharmacol; 2006 Nov 24; 149(6):786-96. PubMed ID: 17016499
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2.
    Xu MJ, Jiang LF, Wu T, Chu JH, Wei YD, Aa JY, Wang GJ, Hao HP, Ju WZ, Li P.
    Chem Biol Interact; 2018 Jun 01; 289():15-22. PubMed ID: 29689254
    [Abstract] [Full Text] [Related]

  • 14. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
    Park SH, Lee J, Shon JC, Phuc NM, Jee JG, Liu KH.
    Phytomedicine; 2018 Mar 15; 42():199-206. PubMed ID: 29655687
    [Abstract] [Full Text] [Related]

  • 15. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Fujisawa M, Yorikane R, Matsuoka Y, Koike H, Ueno K.
    J Cardiovasc Pharmacol; 2013 Jan 15; 61(1):63-9. PubMed ID: 23288106
    [Abstract] [Full Text] [Related]

  • 16. Relationship between lipophilicities of 1,4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice.
    Uesawa Y, Mohri K.
    Yakugaku Zasshi; 2008 Jan 15; 128(1):117-22. PubMed ID: 18176062
    [Abstract] [Full Text] [Related]

  • 17. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L.
    Drug Metab Dispos; 2013 Jan 15; 41(1):60-71. PubMed ID: 23033255
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
    Inomata J, Murai H, Kaneko S, Hamaoka T, Ikeda T, Kobayashi D, Usui S, Furusho H, Sugiyama Y, Takata S, Takamura M.
    J Hypertens; 2014 Sep 15; 32(9):1898-904. PubMed ID: 24979307
    [Abstract] [Full Text] [Related]

  • 19. Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.
    Lin HL, Zhang H, Walker VJ, D'Agostino J, Hollenberg PF.
    Drug Metab Dispos; 2017 Sep 15; 45(9):990-999. PubMed ID: 28698302
    [Abstract] [Full Text] [Related]

  • 20. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.
    Nakamoto M, Ohya Y, Sakima A, Yamazato M, Takishita S.
    Hypertens Res; 2007 Apr 15; 30(4):359-66. PubMed ID: 17541215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.